In this video, Ned describes both the
challenges and
successes of his
myelofibrosis (
MF)
treatment journey. After enrolling in a
clinical trial combining
ruxolitinib and the investigational drug
pelabresib, he experienced significant
drops in hemoglobin that required
frequent transfusions, along with
taste changes, including
ageusia (total loss of taste) and
dysgeusia (distorted taste). Frequent travel to the clinical trial site was another challenge. Over time, his health improved, with better blood counts, reduced bone marrow fibrosis, and a decline in his JAK2 mutation level. He also shares how he
tracks symptoms and lab trends over time to understand how he's doing between visits.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about myeloproliferative neoplasms which will help other patients, caregivers, and families.